From time to time, amendments to research projects are required often due to protocol changes, updated investigator brochures, personnel changes on the study, site additions, and more. Researchers and sponsors must notify the HREC of such changes. 

Review process

The majority of amendments are reviewed out of session and do not require review at the HREC meeting nor submission by a certain deadline. When deemed necessary, amendments are sent to the scientific and/or ethics spokespersons for the project, both of whom are members of the HREC. They will determine whether the amendment can be approved by spokesperson review or whether more detailed consideration is required. If detailed consideration is required, the matter will be listed for discussion at the next HREC meeting.

Amendments to QA projects

Amendments to QA projects are no longer possible.

If there are any changes required to the project a new QA project will need to be submitted to

Instructions for submitting amendments for ethics or governance projects

  1. Download and carefully review the Amendment Guidelines
  2. Complete and submit:
  1. Open the email template: and enter all information as requested:
  • Important to include the local project number in the subject of the email
  • Once you have all the files that you want to submit, you need to compress them into a zipped folder. If using Windows: Select the files, right-click on them, and select Send to > Compressed (zipped) Folder.
  1. Submit your Amendment with the zipped folder. Ensure you receive the acknowledgment email from the Office for Research.
    If you do not get an acknowledgment email it means that the Office has not received your email submission – contact the Office on +61 3 9342 8530 to resolve the issue.

TIPS: Detail all requested changes in your Amendment submission to avoid delays

For faster review and approval of your amendment request, we ask that you provide details of all the requested changes on the Amendment Request form. For example:

  • Where a PICF amendment is required, ensure the PICF is identified as an item on the Amendment Request Form.
  • Specify if a Sponsor has requested the amendment to the PICF with an explanation for the change
  • Provide an explanation for the proposed change to the PICF especially in relation to rewording previously approved standard clauses
  • If the amendment impacts on an existing agreement (e.g. changes to sponsor name, payments made by sponsor to institution, etc.) state this in the Amendment Request form.

By complying with the above you will ensure that the Ethics and Governance team will be able to review your submission quickly and reduce the time to approval.

Documentation required for specific amendment types

Adding new research personnel

When the Royal Melbourne Hospital (RMH) is the reviewing HREC

As the reviewing HREC, RMH only need to be informed of a change in Principal Investigator or Contact Person (i.e. trial coordinator) at each site in which RMH HREC are providing ethical approval.

Other changes, such as Associate Investigators from sites other than RMH do not need to be submitted to the RMH HREC. However, these amendments are required to be submitted directly to the local site governance office for review.

When RMH is a site (Governance review)

If RMH is a site, all changes in RMH site personnel (Principal Investigators, Associate Investigators, Student Research, Research Coordinator, Contact person) need to be submitted to the Office for Research for review.

Required documentation

  • Additional Personnel Form
  • Curriculum Vitae Form for the new researcher (if not received in the last 3 years). This should be sent via email to
  • Updated PICFs: If the new personnel will be involved in consenting patients please consider adding the new investigator to the PICF. It is acceptable to wait until other PICF changes are being initiated to save numerous version changes. Please state this on the amendment form if that is what you intend to do.
  • If you are adding an investigator (including student researchers) to the project and there is no research agreement in place between RMH and the investigators' organisation, please complete and submit a research collaboration agreement (MACH template) between Melbourne Health (Legal entity name for RMH) and the investigators' organisation.
    Note: the new agreement must not be in conflict with existing agreements for the project.
    Submit the new draft and all existing agreements for review.
  • GCP training – Provide copies of GCP certificates for all members of the RMH research team. GCP training remains current for 3 years. For more details and requirements refer to the Education and Training webpage.
Changing sponsor or Coordinating Principal Investigator (CPI) or Principal Investigator (PI)
  • For change of sponsor - provide a letter from the sponsor stating they are now sponsor of the study
  • For change of Coordinating Principal Investigator (CPI) or Principal Investigator (PI) - complete the Additional Personnel Form for the new CPI/PI, signed by both the old and new CPI/PI
  • Curriculum Vitae Form of the new CPI/PI (if not received in the last 3 years). This should be emailed to
  • Updated PICFs with name of new sponsor/PI
  • If commercially sponsored - Updated indemnities, CTN and CTRA as required
  • If not commercially sponsored - state on amendment form that no other updated documents are required.
Adding a new study site

Generally, this can only be done for studies that have been reviewed under the Streamlined Ethical Review Process (SERP) or the National Mutual Acceptance (NMA) system. For studies that do not fit into these categories, please contact the Office for Research for information on your options for adding a study site.

For sites that do not use Ethics Review Manager (ERM) - which are sites outside of Victoria and Queensland - contact the Coordinating Office by telephone for assistance when creating an SSA for these sites on +614 0827 4054.

  • If converting from a single site to multisite project submit a new master PICF.
  • If commercially sponsored - Updated CTN and Indemnities as required
  • If radiation involved (including pre-MRI safety screening examinations) – If standard care, submit the HREC radiation notification letter to be completed and signed by the Principal Investigator for each site. If additional to standard clinical care, an independent assessment report by a Medical Physicist (RSO report) must be included in the submission - one report for each applicable site.
  • If new site is Catholic institution - site specific PICF with Catholic approved pregnancy wording
  • If addition of the new site involves a new collaboration between RMH and another institution and there is not a research agreement in place between these two institutions, you will need to submit an agreement for review and signing. Please refer to the governance page for details on research agreements.
  • Addition of a Private Site: Where RMH is the reviewing HREC, the private site/s being added under RMH ethics approval need to confirm they accept the conditions of RMH HREC review by signing an agreement to undertake ethical review of human research for an external entity.
    This agreement only needs to be signed once per private organisation (not per study). Please contact the Office for Research to see if there is already an agreement in place. If not, a private site agreement will be required.

  • Additional Personnel Form

  • Curriculum Vitae Form for the new researcher (if not received in the last 3 years). This should be sent via email to

Adding a new recruitment site

One of the most common questions the Office receives is around the definition of "recruitment" sites versus "study" sites. We ask that you read the following before adding a new recruitment site to ensure that you are applying for the appropriate approval and to avoid delays in obtaining approval.

What is a recruitment site?

A recruitment site is where the site is only providing information via advertisements, such as a flyer or study poster, regarding a study occurring at another site.

What is a study site?

A study site is where:

  • the site intends to consent or conduct any study procedure; or
  • any investigators are involved in discussing the study with potential participants - this would require the investigators to be trained in the protocol; or
  • any investigators are involved in the study in any way other than displaying advertisements such as a flyer or study poster; or
  • a governance application is required at the new site.

If any of the cases above apply, you are required to complete the procedure for adding a new study site.

How to add a new recruitment only site

To add a recruitment only site, submit the following:

  • Statement of Approval from Head of Department at recruitment site; and
  • Any recruitment materials going to participants
Changing protocol
  • Clear description of the rationale for the changes (including a summary of changes) to the protocol and whether this warrants Participant Information and Consent Forms (PICF) changes. If PICF changes are required, consider using a PICF addendum and outline if/how patients will be re-consented.
  • Tracked and clean version of protocol/PICF
  • If increase in number of tests/visits:
    • Updated statement of approval from relevant service departments
    • Updated budget for sign off by Management Accountant - Research
    • Updated Clinical Trial Research Agreement
Updating the Investigator Brochure

Clear description of the changes, including a summary of changes, and note whether this amendment warrants PICF changes.

If updating the risk statement of the PICF ensure that the changes are in lay language.

New collaboration - samples/data sent off-site

For investigator-initiated studies where you would like to have additional tests/data sent to a new collaborator - e.g. blood samples to the Walter Eliza Hall Institute for extra/new testing.

  • Additional Personnel Form for the new collaborator
  • Curriculum Vitae for new collaborator to be emailed to
  • Updated protocol of what new collaborator is doing. eg how are samples/data being sent (must be de-identified), for how long and how/when will they be destroyed.
  • Updated PICF informing participants that their data/samples are going offsite and, if required, include whether the data/samples are coded, how long they will be kept for and how they will be destroyed.
  • An agreement between the RMH Principal Investigator and the collaborator. The type of agreement depends on the nature of the collaboration. Please contact the Governance team to discuss before submission. As a rough guide:
    • Material Transfer Agreement - if you are giving the samples to a third party and have no further involvement.
    • Research Collaboration Agreement - if you are giving the samples to a third party and obtaining results back from them (eg. the research is now jointly badged).
Changes to an agreement, new agreement, indemnity, budget

For “non-ethics” amendments , eg changes to an agreement, addition of a new agreement, indemnity, budget etc., researchers must submit:

  • A signed Amendment Request Form that clearly and describes in detail the following:
    • The nature of the change
    • The reason for the change; and
    • If the amendment involves a financial transaction (eg change to budget), a calculation of the financial value of the transaction.
  • Amendments involving changes which may impact on services provided by supporting departments, eg radiology, pharmacy, pathology, etc. must also be accompanied by signed Statements of Approval from the relevant supporting department head.


Contact us if you need an accessible version of a download.